—>
Main Menu

Drugs deal

TC BioPharm and Scotia forge partnership

Angela ScottTC BioPharm and Scotia Biologics have announced a strategic collaboration on cancer treatments.

Aberdeen-based Scotia’s chief executive, Keith Charlton said the partnership represents a new focus by investing in longer-term revenue generation. 

TCB’s chief perating officer, Angela Scott (pictured) said it would give TCB all the tools to rapidly develop a broad platform of treatments against a wide variety of cancer and anti-viral targets.  

The collaboration is TCB’s first inward partnering deal.

 



Leave a Reply

Your email address will not be published. Required fields are marked as *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.